MyFinsight
Home
Blog
About
Contact
Download
Download image
Issuance of series d
preferred stock and...
$5,549,207
Proceeds from 3.6m
streeterville note, net
$3,000,000
Net cash provided by
financing activities
$2,936,326
Canceled cashflow
$5,612,881
Net change in cash
and cash...
$1,445,932
Canceled cashflow
$1,490,394
something is missing
-$5,099,207
Principal repayments on
the 2.5m...
$450,000
Repayments of financed
insurance premiums
$63,674
Stock-based compensation
$376,100
Prepaid and other
current assets
-$257,303
Accounts payable
$93,337
Warrants issued to
non-employees
$78,761
Accrued liabilities
$68,179
Amortization - right-of-use
assets, operating lease
$26,322
Amortization of debt
discounts and deferred...
$21,287
Depreciation
$6,916
Purchase of property and
equipment
-$9,476
Net cash used in
operating activities
-$1,462,526
Net cash used in
investing activities
-$27,868
Canceled cashflow
$928,205
Canceled cashflow
$9,476
Net loss
-$1,985,208
Acquisition of intellectual
property - intangibles
$37,344
Capitalized software
$258,420
Deferred offering costs
$116,707
Lease liability,
operating lease
-$30,396
Back
Back
Cash Flow
source: myfinsight.com
HeartSciences Inc. (HSCSW)
HeartSciences Inc. (HSCSW)